Point72 Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $57.9M | Buy |
|
|||||
|
2023
Q1 | $33.1M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $45.5M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $5.86M | Buy |
|
|||||
|
2020
Q4 | $5.07M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $22.9M | Sell |
|
|||||
|
2020
Q1 | $25.4M | Sell |
|
|||||
|
2019
Q4 | $46.7M | Sell |
|
|||||
|
2019
Q3 | $28.9M | Buy |
|
|||||
|
2019
Q2 | $29.9M | Buy |
|
|||||
|
2019
Q1 | $24.8M | Sell |
|
|||||
|
2018
Q4 | $16.9M | Sell |
|
|||||
|
2018
Q3 | $61.3M | Buy |
|
|||||
|
2018
Q2 | $6.96M | Buy |
|